Australia’s medical cannabis industry is on a remarkable growth trajectory, with revenues projected to double from approximately USD $600 million in 2024 to over USD $1.2 billion by 2028, according to the Global Cannabis Report: 5th Edition by Prohibition...
The Greek medical cannabis industry is experiencing rapid growth, with Curity Pharma emerging as a key player in its evolution. On March 4, 2025, Curity Pharma announced that it had secured its operating license from Greek regulatory authorities. This milestone grants...
Neobi is excited to contribute to this year’s CCX Annual Report with data driven insights derived from several of our data sources. The Extracts category saw strong early-year growth but declined in Q4, likely due to seasonal demand or competition. Innovative product...
In 2024, cannabis companies saved significantly by reassessing insurance portfolios. By year-end, many insurers adopted assertive underwriting to meet new business goals. With new market entrants, the 2025 outlook is favorable for cannabis industry insurance buyers....
Since 2021, the unpaid Canada Revenue Agency (“CRA”) excise tax has been a growing concern for the government agency and unpaid amounts ballooned to $273.4 million in 2023[1]. In response to the increasing amount of unpaid taxes, the CRA has announced it will force...
